A5020964564- Systemic Lupus Erythematosus Research
- Pregnancy and Medication Impact
- Rheumatoid Arthritis Research and Therapies
- Monoclonal and Polyclonal Antibodies Research
- Maternal Mental Health During Pregnancy and Postpartum
- Parkinson's Disease and Spinal Disorders
- Eosinophilic Disorders and Syndromes
- Endometriosis Research and Treatment
- Adolescent and Pediatric Healthcare
- Inflammatory Myopathies and Dermatomyositis
- Skin Diseases and Diabetes
Universidad Autónoma de Nuevo León
2019-2021
Hospital Universitario Dr José Eleuterio Gonzalez
2019-2021
<h3>Background</h3> The idiopathic inflammatory myopathies (IIM) are a heterogeneous group of subacute, chronic, or acute acquired diseases skeletal muscle, they can be classified into the following clinical pathologic groups: dermatomyositis (DM), polymyositis (PM), and inclusion body myositis (IBM) which differ in presentation, season onset, genetics, prognosis.(<sup>1</sup> Furthermore, seropositivity antibodies these help to predict evolution disease, influence therapeutic...
Background: The importance of safe and effective contraception for women with rheumatic diseases has been increasing. 1 Several studies have demostrated that carefully planned pregnancies are related better outcomes making the use contraceptive methods (CM) more significant. Objectives: To describe among Rheumatoid Arthritis (RA) Systemic Lupus Erythematosus (SLE). Methods: A Cross-sectional study where aged 18-45 followed in our CEER outpatient clinic, at Monterrey, Mexico, were questioned...
Background: Some studies have suggested an increased risk of adverse health outcomes for the child patients with Rheumatic Diseases (RD), including neurodevelopmental disorders, congenital heart defects, hematological malignancies and autoimmune diseases. It is well known that 2 to 3% live births a defect. About 7 % all newborn deaths are due birth defects. Objectives: Describe Genetical Evaluation in cohort pregnant RD Methods: We included 22 women from February December 2019 Clinic...
Background: Pregnancy in women with autoimmune rheumatic diseases (ARD) is associated an increase the risk of adverse perinatal outcomes and birth defects. Many factors have been attributed to these including medication employed maternal autoantibodies. The national prevalence congenital anomalies newborns Mexico estimated be 73.9 per 10,000 births but rate Mexican ARD unknown. Objectives: This study aims describe frequency defects ARD. Methods: We performed a descriptive prospective that...